Procter & Gamble Hygiene and Health Care DuPont analysis

·FMCG & RetailChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY27Jun 2026FY26Jun 2025FY25Jun 2024FY24Jun 2023FY23 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY23 and earlierEvery year the company has filed comes with Alpha Plus.
0.74×0.73×0.72×0.81×
1.06×1.03×1.03×1.04×
18.0%27.4%21.7%20.7%
——2.11×2.05×
——2.40×2.26×
——81.2%80.2%
——78.5%80.6%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

PGHH₹6,923.50

Procter & Gamble Hygiene and Health Care Limited

· FMCG & Retail
₹ CrorePeersBAJAJCONJHSMcap ₹22,474 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
30/06/2023
FY25
30/06/2024
FY26
30/06/2025
FY27
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.810.720.730.74
Interest Burden (Pretax/EBIT) ×1.041.031.031.06
EBIT Margin %20.6821.7327.4418.00
Asset Turnover ×2.052.11——
Financial Leverage (Assets/Equity) ×2.262.40——
ROE (5-step product, year-end total equity) %80.1681.23——
ROE (owners' profit / average owners' equity) %80.5678.45——
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY27 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.